Ipilimumab/Nivolumab-related orthostatic myoclonus in a patient with metastatic melanoma
Objective: To describe a case of delayed onset Orthostatic Myoclonus in a patient after withdrawal of checkpoint inhibitor immunotherapy. Background: Movement disorders have been described…Impaired lysophagy function exacerbates propagation of α-synuclein aggregation
Objective: We aimed to clarify how exogenous αSyn aggregates interact with native αSyn in the cytoplasm and seed aggregation, and what defense mechanisms protect against…Genetic and phenotypic characterization of ATX-FAT2 (SCA45) in three Indian families
Objective: Delineation of clinical and genetic features of Spinocerebellar ataxia 45 (SCA45) in three families of Indian origin. Background: SCA45 has been reported in few…IP-RT-QuIC Identify Disease-Specific Alpha-Synuclein Seeds in serum from patients with syncleinopathy
Objective: To examine whether alpha-synuclein (aSyn) seed exists in the serum and its potential as a serum biomarker. Background: Parkinson’s disease (PD) and Multiple system…A clinical case of subdural hematoma caused by a tic-like head banging in a patient with neurodevelopmental disorder
Objective: To describe a case of subdural hematoma caused by a tic-like head banging. Background: Subdural hematoma is a medical condition that occurs when blood…Exome-wide and Mitogenome Sequencing of Indian Dystonia Patients
Objective: To identify whole exome and mitochondrial genome mutation spectrum of dystonia in India and to establish clinical significance of mutations by phenotype-genotype correlation. Background:…Premonitory urge in patients with tics and functional tic-like behaviors
Objective: To compare premonitory urges (PU) in patients with tics and functional tic-like behaviors (FTB). Background: Previous case series have suggested that patients with functional…White matter lesions and motor symptoms in Parkinson’s disease
Objective: Objective: To investigate the association between cerebral white matter lesions (WML) and motor symptoms in Parkinson’s disease (PD). Background: Background: Previous studies have shown…Proof-of-concept clinical trial: Prevent cognitive decline in GBA-associated Parkinson’s Disease
Objective: To prevent cognitive decline in GBA-associated Parkinson’s Disease (PD). Background: Dementia represents a key milestone in the course of PD with limited effective treatments…Pseudogout Mimicking Stiffness in Parkinson’s Disease: A Case Report
Objective: N/A Background: Levodopa-responsive muscular rigidity is one of the hallmarks of Parkinson’s disease (PD). Many rheumatological conditions can present with stiffness1-4. For example, polymyalgia…
- « Previous Page
- 1
- …
- 140
- 141
- 142
- 143
- 144
- …
- 186
- Next Page »